Metabolic health Clinical Trials in Austin, TX
As of August 2026, 26 paid clinical trials are recruiting for Metabolic health in Austin, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Austin
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
31 clinical trials for Metabolic health
·Clear filters·A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
Semaglutide for Post-Smoking Cessation Weight Management
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Top Research Study Locations in Austin
Researchers run research studies in Austin, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dell Children's Medical Center of Central Texas | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 33 |
| University of Texas at Austin | Stroke, Alcohol Drinking, Alzheimer Disease | 23 |
| The University of Texas at Austin | Attention Deficit Hyperactivity Disorder, Healthy, Multiple Sclerosis | 22 |
| FutureSearch Trials of Neurology | Osteoarthritis, Knee, Chronic Pain, Migraine | 14 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Asthma | 13 |
| Texas Cardiac Arrhythmia Research Foundation | Atrial Fibrillation, Heart Failure, Paroxysmal AF | 12 |
| Austin Clinical Trial Partners | Major Depressive Disorder, Depression, Generalized Anxiety Disorder | 10 |
| Austin Heart | Heart Failure, Obesity, Heart Failure With Preserved Ejection Fraction | 10 |
| Dell Children's Medical Center | AAOCA, Acute Treatment of Migraine, Adolescent Idiopathic Scoliosis | 10 |
| Urology Austin | Prostate Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Bladder (Urothelial, Transitional Cell) Cancer | 10 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Advanced or Metastatic Renal Cell Carcinoma | 9 |
| NEXT Austin | Advanced Solid Tumors, Endometrial Cancer, Advanced Solid Tumor | 9 |
| Texas Oncology - Central/South Texas | Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer | 8 |
| National Neuromuscular Research Institute | Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis | 8 |
| Texas Oncology | Multiple Myeloma, Any Solid Oral Medication, CRC (Colorectal Cancer) | 8 |
| Austin Retina Associates | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD) | 7 |
| St. David's South Austin Medical Center | AML, MDS, Multiple Myeloma | 7 |
| Ascension Texas Cardiovascular | Aortic Valve Stenosis, Cardiovascular Diseases, Pulmonary Hypertension | 6 |
| IMA Clinical Research Austin | Obesity, Overweight, Liver Fibrosis | 6 |
| NEXT Oncology | Locally Advanced (Unresectable) or Metastatic Solid Tumors, Ovarian Cancer, Solid Tumor | 6 |
| University of Texas | Logopenic Progressive Aphasia, Logopenic Progressive Aphasia (LPA), Logopenic Variant Primary Progressive Aphasia | 6 |
| Austin Neuromuscular Center | Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) | 5 |
| Austin Clinical Research, LLC | Diabetic Macular Edema, Geographic Atrophy, Macular Edema | 5 |
| Dell Children's Blood and Cancer Center | Neuroblastoma, Medulloblastoma, Pediatric Cancer | 5 |
| Dell Seton Medical Center at The University of Texas | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 5 |
Active & Upcoming Studies in Austin (2026)
Recruiting trials in Austin grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (173 active studies)
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Diabetes & metabolic (52 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
Neurology & pain (51 active studies)
- Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children · Baylor College of Medicine
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
Mental health & behavior (48 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Self-Compassion, Health, and Empowerment · Yang Li
Cardiovascular (43 active studies)
- Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation · Boston Scientific Corporation
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Eye & vision (23 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Pediatric (12 active studies)
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
- Pressure Targeting During High Flow Therapy in Premature Infants · Phase 2 · University of Texas at Austin
Vaccines (4 active studies)
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older · Phase 1, Phase 2 · Sanofi
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
HIV / STI (4 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Common conditions studied in Austin
- Obesity (22 active studies)
- Overweight (17 active studies)
- Heart Failure (15 active studies)
- Endometrial Cancer (13 active studies)
- Breast Cancer (12 active studies)
- Schizophrenia (12 active studies)
Leading research sponsors in Austin
- University of Texas at Austin
- AbbVie
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Austin?
There are approximately 685 recruiting clinical trials in Austin, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Austin pay participants?
Most recruiting trials in Austin compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Austin?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Austin?
The most common conditions under active study in Austin include Obesity (22), Overweight (17), Heart Failure (15), Endometrial Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Austin?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Austin on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Austin?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Austin?
Recruiting research sites in Austin include Dell Children's Medical Center of Central Texas, University of Texas at Austin, The University of Texas at Austin, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Austin right now?
The largest active categories in Austin are Cancer & tumors (173), Diabetes & metabolic (52), Neurology & pain (51). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.